Abstract
Indole-3-acetic acid and indole-3-propionic acid, two potent natural plant growth hormones, have attracted attention as promising prodrugs in cancer therapy. Copper is known to be a cofactor essential for tumor angiogenesis. We have previously reported that taurine, l-glutamine, and quinoline-2-carboxaldehyde Schiff base copper complexes inhibit cell proliferation and proteasome activity in human cancer cells. In the current study, we synthesized two types of copper complexes, dinuclear complexes and ternary complexes, to investigate whether a certain structure could easily carry copper into cancer cells and consequently inhibit tumor proteasome activity and induce apoptosis. We observed that ternary complexes binding with 1,10-phenanthroline are more potent proteasome inhibitors and apoptosis inducers than dinuclear complexes in PC-3 human prostate cancer cells. Furthermore, the ternary complexes potently inhibit proteasome activity before induction of apoptosis in MDA-MB-231 human breast cancer cells, but not in nontumorigenic MCF-10A cells. Our results suggest that copper complexes binding with 1,10-phenanthroline as the third ligand could serve as potent, selective proteasome inhibitors and apoptosis inducers in tumor cells, and that the ternary complexes may be good potential anticancer drugs.
Similar content being viewed by others
Abbreviations
- DMSO:
-
Dimethyl sulfoxide
- IAA:
-
Indole-3-acetic acid
- IPA:
-
Indole-3-propionic acid
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- PARP:
-
Poly(ADP-ribose) polymerase
- ROS:
-
Reactive oxygen species
- Suc-LLVY-AMC:
-
N-Succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
References
Bennett MJ, Marchant A, May ST, Swarup R (1998) Philos Trans R Soc Lond B Biol Sci 353:1511–1515
Grossmann K (2010) Pest Manag Sci 66:113–120
Kim SY, Ryu JS, Li H, Park WJ, Yun HY, Baek KJ, Kwon NS, Sohn UD, Kim DS (2010) Anticancer Res 11:4607–4612
Kima D-S, Jeonb S-E, Parkb K-C (2004) Cell Signal 16:81–88
Jeong Y-M, Oh MH, Kim SY, Li H, Yun H-Y, Baek KJ, Kwon NS, Kim WY, Kim D-S (2010) Pharmazie 65:122–126
Karbownik M, Reiter RJ, Garcia JJ, Cabrera J, Burkhardt S, Osuna C, Lewiński A (2001) J Cell Biochem 3:507–513
Tapiero H, Townsend DM, Tew KD (2003) Biomed Pharmacother 57:386–398
Linder M (1991) Biochemistry of copper. Plenum Press, New York
Labbe S, Thiele DJ (1999) Trends Microbiol 7:500–505
Aggett PJ, Fairweather-Tait S (1998) Am J Clin Nutr 67(5 Suppl):1061S–1063S
Finney L, Vogt S, Fukai T, Glesne D (2009) Clin Exp Pharmacol Physiol 36:88–94
Eatock MM, Schatzlein A, Kaye SB (2000) Cancer Treat Rev 26:191–204
Dutcher JP (2001) Curr Oncol Rep 3:353–358
Fox SB, Gasparini G, Harris AL (2001) Lancet Oncol 2:278–289
Gourley M, Williamson JS (2000) Curr Pharm Des 6:417–439
Hochstrasser M (1995) Curr Opin Cell Biol 7:215–223
Orlowski RZ, Dees EC (2003) Breast Cancer Res 5:1–7
Clechanover A (1994) Cell 79:13–21
Voges D, Zwickl P, Baumeister W (1999) Annu Rev Biochem 68:1015–1068
Seemuller E, Lupas A, Stock D, Lowe J, Huber R, Baumeister W (1995) Science 268:579–582
Sun J, Nam S, Lee C-S, Li B, Coppola D, Hamilton AD, Dou QP, Sebti SM (2001) Cancer Res 61:1280–1284
Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ (1999) Cancer Res 59:2615–2622
Imajoh-Ohmi S, Kawaguchi T, Sugiyama S, Tanaka K, Omura S, Kikuchi H (1995) Biochem Biophys Res Commun 217:1070–1077
Shinohara K, Tomioka M, Nakano H, Tone S, Ito H, Kawashima S (1996) Biochem J 317:385–388
Drexler HC (1997) Proc Natl Acad Sci USA 94:855–860
Yang HJ, Chen D, Cui QC, Yuan X, Dou QP (2006) Cancer Res 66:4758–4765
An B, Dou QP (1996) Cancer Res 56:438–442
Daniel KG, Chen D, Orlu S, Cui QC, Miller FR, Dou QP (2005) Breast Cancer Res 7:897–908
Chen D, Peng F, Cui QC, Daniel KG, Qrlu S, Liu J, Dou QP (2005) Front Biosci 10:2932–2939
Fan YH, Dong LL et al (2012) Russ J Coord Chem 38:1–7
Chen D, Cui QC, Yang HJ, Dou QP (2006) Cancer Res 66:10425–10433
Zhang X, Bi C, Fan Y, Cui Q, Chen D, Xiao Y, Dou QP (2008) Int J Mol Med 22:677–682
Daniel KG, Gupta P, Harbach RH, Guida WC, Dou QP (2004) Biochem Pharmacol 67:1139–1151
Xiao Y, Bi C, Fan Y, Cui C, Zhang X, Dou QP (2008) Int J Oncol 33:1073–1079
Nakamoto K, Huang DR, Wang QR (1988) Infrared and Raman spectra of inorganic and coordination compounds. Chemical Industry Press, Beijing
Gong QJ, Jin WJ, Dong C (2000) Appl Chem 17:227–229
Li B, Dou QP (2000) Proc Natl Acad Sci USA 97:3850–3855
Li L, Yang H, Chen D, Cui C, Dou QP (2008) Toxicol Appl Pharmacol 229:206–214
Daniel KG, Harbach RH, Guida WC, Dou QP (2004) Front Biosci 9:2652–2662
Ryan CJ, Wilding G (2000) Drugs Aging 17:249–255
Adams J (2003) Drug Discov Today 8:307–315
Almond JB, Cohen GM (2002) Leukemia 16:433–443
Dou QP, Li B (1999) Drug Resist Updates 2:215–223
Pufahl RA, Singer CP, Peariso KL, Lin SJ, Schmidt PJ, Fahrni CJ, Culotta VC, Penner-Hahn JE, O’Halloran TV (1997) Science 278:853–856
Tardito S, Bussolati O, Maffini M, Thioamido LM (2007) J Med Chem 50:1916–1924
Uriu-Adams JY, Keen CL (2005) Mol Aspects Med 26:268–298
Kachadouriana R, Brechbuhla HM, Ruiz-Azuarab L, Gracia-Morab I (2010) Toxicology 268:176–183
Nicco C, Laurent A, Chereau C (2005) Biomed Pharmacother 59:169–174
Armstrong JS (2006) Br J Pharmacol 147:239–248
Zhai S, Yang L, Cui QC, Sun Y, Dou QP, Yan B (2010) J Biol Inorg Chem 15:259–269
Milacic V, Chen D, Ronconi L, Landis-Piwowar KR, Fregona D, Dou QP (2006) Cancer Res 66:10478–10486
Zhang X, Frezza M, Milacic V, Ronconi L, Fan Y, Bi C, Fregona D, Dou QP (2010) J Cell Biochem 109:162–172
Acknowledgments
This research was supported by grants from the National Science Foundation of China to C.B. (no. 21071134) and Y.F. (no. 20971115) and from the National Cancer Institute (1R01CA20009, 3R01CA120009-04S1, and 5R01CA127258-05) to Q.P.D. and a scholarship from the Chinese Scholarship Council to Z.Z.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, Z., Bi, C., Schmitt, S.M. et al. 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity. J Biol Inorg Chem 17, 1257–1267 (2012). https://doi.org/10.1007/s00775-012-0940-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-012-0940-x